Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 121 - 130 of 198 Results.

Political Promises Won’t Lower Insulin Prices
Raymond J. March | Commentary | Mar. 12, 2020
House Bill Seeking Price Controls on Drugs Would Cause Millions to Die
Ronald L. Trowbridge | Commentary | Dec. 21, 2019
The Emerging New Face of Affordable Health Care
Conor Norris | Commentary | Nov. 12, 2019
How Trump Is Reforming Medicare, Part II
Lawrence J. Wedekind, John C. Goodman | Commentary | July 18, 2019
All I Want for Christmas Is a Government Shutdown
Benjamin Powell | Commentary | Dec. 20, 2018
The Liberal Plantation
John C. Goodman | Commentary | Nov. 26, 2018
Lower Cost, Higher Quality Health Care Is Right at Our Fingertips
John C. Goodman | Commentary | July 27, 2018
Legalizing Pot Sales Means...Higher Home Values?
Art Carden | Commentary | July 18, 2018
Right-to-Try Is Just What the Doctor Ordered
Raymond J. March | Commentary | July 18, 2018
Can the Market Really Work in Health Care?
John C. Goodman | Commentary | May 30, 2018






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL